Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST): Nilotinib PK
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Gastrointestinal Stromal Tumors
Related studies linked through entity extraction aliases.
Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting
- Status
- COMPLETED
- Phase
- N/A
Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)
- Status
- TERMINATED
- Phase
- PHASE3
Nilotinib in Advanced Gastrointestinal Stromal Tumors (GIST)
- Status
- TERMINATED
- Phase
- PHASE2
Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib
- Status
- COMPLETED
- Phase
- PHASE4
Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg
- Status
- TERMINATED
- Phase
- PHASE3
Efficacy and Safety of AMN107 in Patients With GastroIntestinal Stromal Tumors (GIST) Who Have Failed Both Imatinib and Sunitinib
- Status
- COMPLETED
- Phase
- PHASE2
A Retrospective Clinical Records Review of Patients Diagnosed With Gastrointestinal Stromal Tumour at Two Tertiary Institutes in Singapore
- Status
- COMPLETED
- Phase
- N/A
Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan).
- Status
- COMPLETED
- Phase
- N/A
Study Evaluating IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) Following Failure of at Least Imatinib and Sunitinib
- Status
- TERMINATED
- Phase
- PHASE3
Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib
- Status
- COMPLETED
- Phase
- PHASE2
Current Management of Gastrointestinal Stromal Tumors (GIST) in the Region of Coquimbo
- Status
- COMPLETED
- Phase
- N/A
Gastrointestinal Stromal Tumors (GIST) Registry
- Status
- COMPLETED
- Phase
- N/A
Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Nilotinib (AMN107) Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ph II Study of Perifosine Plus Gleevec for Patients With GIST
- Status
- COMPLETED
- Phase
- PHASE2
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene
- Status
- COMPLETED
- Phase
- N/A
Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib
- Status
- COMPLETED
- Phase
- PHASE1